619
Participants
Start Date
December 4, 2012
Primary Completion Date
April 30, 2014
Study Completion Date
April 4, 2014
Cebranopadol (GRT6005) Low-Dose Range
Capsules
Cebranopadol (GRT6005) High-Dose Range
Capsules
Placebo
Capsules that did not contain active substance but appeared identical to the cebranopadol and oxycodone CR capsules
Oxycodone CR
Capsules containing oxycodone CR 10 or 20 milligrams
Site 017, Hartsdale
Site 068, Albany
Site 045, Altoona
Site 002, Duncansville
Site 077, Wheaton
Site 088, Towson
Site 026, Virginia Beach
Site 092, Norfolk
Site 006, High Point
Site 056, Greensboro
Site 078, Wilmington
Site 076, Charleston
Site 034, Anderson
Site 052, Marietta
Site 073, Stockbridge
Site 033, Perry
Site 090, Edgewater
Site 025, Ormond Beach
Site 060, Jacksonville
Site 032, Orlando
Site 058, Pembroke Pines
Site 013, Miami
Site 015, Jupiter
Site 071, Clearwater
Site 091, Pinellas Park
Site 011, Bradenton
Site 007, Sarasota
Site 012, Ocala
Site 003, New Port Richey
Site 051, Birmingham
Site 022, Birmingham
Site 031, Huntsville
Site 093, Bristol
Site 001, Columbus
Site 048, Toledo
Site 069, Cleveland
Site 079, Cincinnati
Site 008, Cincinnati
Site 041, Indianapolis
Site 085, Valparaiso
Site 016, Bingham Farms
Site 042, Traverse City
Site 086, Chicago
Site 023, St Louis
Site 074, Omaha
Site 087, Grand Island
Site 075, Oklahoma City
Site 038, Dallas
Site 082, Wichita Falls
Site 049, Bryan
Site 089, San Antonio
Site 040, San Antonio
Site 055, Austin
Site 019, Draper
Site 059, Salt Lake City
Site 064, Ogden
Site 005, Phoenix
Site 018, Phoenix
Site 070, Phoenix
Site 028, Tucson
Site 009, Albuquerque
Site 024, Las Vegas
Site 072, Las Vegas
Site 027, Westlake Village
Site 084, North Hollywood
Site 081, Chino
Site 030, El Cajon
Site 044, San Diego
Site 043, Tustin
Site 061, Fresno
Site 010, Walnut Creek
Site 039, Fair Oaks
Site 080, Roseville
Site 004, Sacramento
Site 035, Portland
Site 067, Medford
Site 029, Bend
Site 066, Bellevue
Site 057, Renton
Site 065, Seattle
Site 083, New Bedford
Site 021, North Dartmouth
Site 020, Worcester
Collaborators (1)
Forest Laboratories
INDUSTRY
Tris Pharma, Inc.
INDUSTRY